HIV infection is associated with numerous adverse renal manifestations, including HIV-associated nephropathy (HIVAN), HIV-associated immune complex kidney disease (HIVICD), and other glomerulonephritides
Renal biopsy in patients infected with HIV is essential to differentiate HIVICD from other forms of HIV-associated kidney diseases, such as HIVAN or nephrotoxicity
The development of HIVICD is the result of the complex interplay between host–pathogen interactions, genetic susceptibility, and environmental factors
Data regarding the optimal treatment strategy for patients with HIVICD are limited
The introduction in the late 20th century of combination antiretroviral therapy (cART) to treat patients infected with HIV has changed the natural history of the disease from an acute illness that rapidly culminates in death, to a chronic condition that can be managed with medications. Over the past decade the epidemiology of kidney disease in US patients infected with HIV has changed, perhaps because of the increased availability and use of cART. Patients with HIV infection exhibit unique immunologic characteristics, including immunodeficiency and dysregulation of immunoglobulin synthetic responses and T-cell function, which can result in glomerular immune complex deposition and subsequent kidney injury. This Review examines the differential diagnoses of HIV-associated immune complex kidney diseases (HIVICD), and discusses the clinical manifestations and mechanisms underlying their development. We address the issues associated with treatment, clinical outcomes, and research needs to enhance our ability to diagnose and optimally treat patients with HIVICD.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
BMC Nephrology Open Access 17 March 2022
BMC Nephrology Open Access 18 September 2020
Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases
BMC Nephrology Open Access 20 November 2018
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Fernando, S. K., Finkelstein, F. O., Moore, B. A. & Weissman, S. Prevalence of chronic kidney disease in an urban HIV infected population. Am. J. Med. Sci. 335, 89–94 (2008).
Szczech, L. A. et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 61, 195–202 (2002).
Rao, T. K. et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310, 669–673 (1984).
Pardo, V. et al. Glomerular lesions in the acquired immunodeficiency syndrome. Ann. Intern. Med. 101, 429–434 (1984).
Rosenberg, A. Z., Naicker, S., Winkler, C. A. & Kopp, J. B. HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment. Nat. Rev. Nephrol. 10, 150–160 (2015).
Benveniste, O. et al. Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir. Clin. Infect. Dis. 28, 1180–1181 (1999).
Rao, T. K. Acute renal failure in human immunodeficiency virus infection. Semin. Nephrol. 18, 378–395 (1998).
Kopp, J. B. et al. Crystalluria and urinary tract abnormalities associated with indinavir. Ann. Intern. Med. 128, 118–125 (1997).
Kopp, J. B. et al. Indinavir-associated interstitial nephritis and urothelial inflammation: clinical and cytologic findings. Clin. Infect. Dis. 34, 1122–1128 (2002).
Olyaei, A. J., deMattos, A. M. & Bennett, W. M. Renal toxicity of protease inhibitors. Curr. Opin. Nephrol. Hypertens. 9, 473–476 (2000).
Reiter, W. J., Schön-Pernerstorfer, H., Dorfinger, K., Hofbauer, J. & Marberger, M. Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed. J. Urol. 161, 1082–1084 (1999).
Kohan, A. D., Armenakas, N. A. & Fracchia, J. A. Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus. J. Urol. 161, 1765–1768 (1999).
Rao, T. K. Renal complications in HIV disease. Med. Clin. North Am. 80, 1437–1451 (1996).
Wearne, N., Swanepoel, C. R., Boulle, A., Duffield, M. S. & Rayner, B. L. The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. Nephrol. Dial. Transplant. 27, 4109–4101 (2012).
Foy, M. C. et al. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy. Clin. J. Am. Soc. Nephrol. 8, 1524–1532 (2013).
Weiner, N. J., Goodman, J. W. & Kimmel, P. L. The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int. 63, 1618–1631 (2003).
Kimmel, P. L., Barisoni, L. & Kopp, J. B. Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann. Intern. Med. 139, 214–226 (2003).
Rachakonda, A. K. & Kimmel, P. L. CKD in HIV-infected patients other than HIV-associated nephropathy. Adv. Chron. Kidney. Dis. 17, 83–93 (2010).
Cohen, S. D. & Kimmel, P. L. Immune complex renal disease and human immunodeficiency virus infection. Semin. Nephrol. 28, 535–544 (2008).
Kimmel, P. L. et al. Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N. Engl. J. Med. 327, 729–730 (1992).
Kimmel, P. L. et al. HIV-associated immune-mediated renal disease. Kidney Int. 44, 1327–1340 (1993).
Stokes, M. B. et al. Immune complex glomerulonephritis in patients co-infected with HIV and hepatitis C virus. Am. J. Kidney Dis. 29, 514–525 (1997).
Haas, M., Kaul, S. & Eustace, J. A. HIV-associated immune complex glomerulonephritis with 'lupus-like' features: a clinicopathologic study of 14 cases. Kidney Int. 67, 1381–1390 (2005).
Nochy, D. et al. Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol. Dial. Transplant. 8, 11–19 (1993).
Szczech, L. A. et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 66, 1145–1152 (2004).
Schectman, J. M. & Kimmel, P. L. Remission of hepatitis-B associated membranous glomerulonephritis in human immunodeficiency virus infection. Am. J. Kidney Dis. 17, 716–718 (1991).
Kimmel, P. L., Abraham, A. A. & Phillips, T. M. Membranoproliferative glomerulonephritis in a patient treated with interferon-alpha for human immunodeficiency virus infection. Am. J. Kidney Dis. 24, 858–863 (1994).
Praditpornsilpa, K. et al. Renal pathology and HIV infection in Thailand. Am. J. Kidney Dis. 33, 282–286 (1999).
Williams, D. I. et al. Presentation, pathology, and outcome of HIV-associated renal disease in a specialist centre for HIV/AIDS. Sex. Transm. Infect. 74, 179–184 (1998).
Cohen, S. D. & Kimmel, P. L. Renal biopsy is necessary for the diagnosis of HIV-associated renal diseases. Nat. Clin. Pract. Nephrol. 5, 22–23 (2009).
Barbiano di Belgiojoso, G. et al. Immunotactoid glomerulopathy in a HIV-infected patient: a novel association. Nephrol. Dial. Transplant. 11, 857–859 (1996).
Naggie, S. & Hicks, C. Protease inhibitor-based antiretroviral therapy in treatment-naive HIV-1-infected patients: the evidence behind the options. J. Antimicrob. Chemother. 6, 1094–1099 (2010).
Rao, T. K., Friedman, E. A. & Nicastri, A. D. The types of renal disease in the acquired immunodeficiency syndrome. N. Engl. J. Med. 316, 1062–1068 (1987).
Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 (2010).
Kopp, J. B. et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 22, 2129–2137 (2011).
Freedman, B. I. et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J. Am. Soc. Nephrol. 21, 1422–1426 (2010).
Thomson, R. et al. Evolution of the primate trypanolytic factor APOL1. Proc. Natl Acad. Sci. USA 111, E2130–E2139 (2014).
Udler, M. S. et al. Effect of genetic African ancestry on eGFR and kidney disease. J. Am. Soc. Nephrol. 26, 1682–1692 (2014).
Fine, D. M. et al. APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J. Am. Soc. Nephrol. 23, 343–350 (2012).
Matovu, E. et al. Enabling the genomic revolution in Africa. Science 344, 1346–1348 (2014).
D'Agati, V., Suh, J. I., Carbone, L., Cheng, J. T. & Appel, G. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int. 35, 1358–1370 (1989).
Kimmel, P. L., Ferreira-Centeno, A., Farkas-Szallasi, T., Abraham, A. A. & Garrett, C. T. Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int. 43, 1347–1352 (1993).
Cohen, S. D. & Kimmel, P. L. HIV-associated renal diseases in Africa: a desperate need for additional study. Nephrol. Dial. Transplant. 22, 2116–2119 (2007).
Emem, C. P. et al. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features, and risk factors. Nephrol. Dial. Transplant. 23, 741–746 (2008).
Mallipattu, S. K., Salem, F. & Wyatt, C. M. The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. Kidney Int. 86, 259–265 (2014).
Gerntholtz, T. E., Goetsch, S. J. & Katz, I. HIV-related nephropathy: a South African perspective. Kidney Int. 69, 1885–1991 (2006).
Han, T. M., Naicker, S., Ramdial, P. K. & Assounga, A. G. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int. 69, 2243–2250 (2006).
Casanova, S. et al. Pattern of glomerular involvement in human immunodeficiency virus-infected patients: an Italian study. Am. J. Kidney Dis. 26, 446–453 (1995).
Gupta, V. et al. HIV associated renal disease: a pilot study from North India. Indian J. Med. Res. 137, 950–956 (2013).
Glassock, R. J. Immune complex-induced glomerular injury in viral diseases: an overview. Kidney Int. Suppl. 35, S5–S7 (1991).
Killen, P. D., Melcion, C., Bonadio, J. F., Morel-Maroger, L. & Striker, G. E. Glomerular response to immunologic injury, studies on progression. Springer Semin. Immunopathol. 5, 297–320 (1982).
Couser, W. G. & Johnson, R. J. The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int. 86, 905–914 (2014).
Kimmel, P. L. & Phillips, T. M. in Renal and Urologic Aspects of HIV Infection (eds Kimmel, P. L. et al.) 77–110 (Churchill Livingstone, 1995).
Couser, W. G. Basic and translational concepts of immune-mediated glomerular diseases. J. Am. Soc. Nephrol. 23, 381–399 (2012).
Wilson, C. B. & Dixon, F. J. in The Kidney (eds Brenner, B. M. & Rector, F. C. Jr) 838–940 (Saunders, 1976).
Theophilopoulos, A. N. & Dixon, F. J. Immune complexes in human diseases. Am. J. Pathol. 100, 529–594 (1980).
Navalkar, R. G., Norlin, M. & Ouchterlony, O. Characterization of leprosy sera with various mycobacterial antigens using double diffusion-in-gel analysis. Int. Arch. Allergy Appl. Immunol. 25, 105–113 (1964).
Woodroffe, A. J. & Wilson, C. B. An evaluation of elution techniques in the study of immune complex glomerulonephritis. J. Immunol. 118, 1788–1794 (1977).
Kiryluk, K. & Novak, J. The genetics and immunopathology of IgA nephropathy. J. Clin. Invest. 124, 2325–2332 (2014).
Wyatt, R. J. & Julian, B. A. IgA nephropathy. N. Engl. J. Med. 368, 2402–2414 (2013).
Johnson, R. J. et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N. Engl. J. Med. 328, 456–470 (1993).
Nishanian, P., Huskins, K. R., Stehn, S., Detels, R. & Fahey, J. L. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J. Infect. Dis. 162, 21–28 (1990).
Portera, M. et al. Free and antibody-complexed antigen and antibody profile in apparently healthy HIV seropositive individuals and in AIDS patients. J. Med. Virol. 30, 30–35 (1990).
Carini, C. et al. Characterization of specific immune complexes in HIV-related disorders. Scand. J. Immunol. 26, 21–28 (1987).
McDougal, J. S. et al. Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency and disease progression. J. Clin. Invest. 80, 316–324 (1987).
Ellaurie, M., Calvelli, T. & Rubinstein, A. Immune complexes in pediatric human immunodefiency virus infection. Am. J. Dis. Child. 144, 1207–1209 (1990).
Szczech, L. A. et al. The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease. Am. J. Kidney Dis. 48, E55–E59 (2006).
Kimmel, P. L. in Immunologic Renal Diseases 2nd edn (eds Nielson, E. G. & Couser, W. G.) 1203–1223 (Lippincott Williams and Wilkins, 2001).
Shen, X. & Tomaras, G. D. Alterations of the B-cell response by HIV-1 replication. Curr. HIV/AIDS Rep. 8, 23–30 (2011).
Lane, H. C. et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309, 453–458 (1983).
Michael, A. F. Jr, Drummond, K. N., Good, R. A. & Vernier, R. L. Acute poststreptococcal glomerulonephritis: immune complex disease. J. Clin. Invest. 45, 237–248 (1966).
Treser, G. et al. Partial characterization of antigenic streptococcal plasma membrane components in acute glomerulonehritis. J. Clin. Invest. 49, 762–768 (1970).
Nissenson, A. R., Baraff, L. J., Fine, R. N. & Knutson, D. W. Poststreptococcal acute glomerulonephritis: facts and controversy. Ann. Intern. Med. 91, 76–86 (1979).
Gamble, C. N. & Rearsdan, J. B. Immunopathogenesis of syphilitic glomerulonephritis. N. Engl. J. Med. 292, 449–454 (1975).
Gorevic, P. D. et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am. J. Med. 69, 287–306 (1980).
Fabrizi, F. Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence. Scientifica 2012, 128382 (2012).
Ward, P. A. & Kibukamusoke, J. W. Evidence for soluble immune complexes in the pathogenesis of quartan malaria. Lancet 293, 283–285 (1969).
Korbet, S. M. & Schwartz, M. M. Human immunodeficiency virus infection and nephrotic syndrome. Am. J. Kidney Dis. 20, 97–103 (1992).
Bodi, I., Abraham, A. A. & Kimmel, P. L. Macrophages in HIV-associated kidney diseases. Am. J. Kidney Dis. 24, 762–767 (1994).
Ross, M. J. Advances in the pathogenesis of HIV-associated kidney diseases. Kidney Int. 86, 266–274 (2014).
Katz, A. et al. IgA nephritis in HIV-positive patients: a new HIV-associated nephropathy? Clin. Nephrol. 38, 61–68 (1992).
Kajiyama, W., Kopp, J. B., Marinos, N. J., Klotman, P. E. & Dickie, P. Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef. Kidney Int. 58, 1148–1159 (2000).
Mikulak, J. & Singhal, P. C. HIV-1 and kidney cells: better understanding of viral interaction. Nephron Exp. Nephrol. 115, e15–e21 (2010).
Bruggeman, L. A. Insight versus quagmire with compound HIV transgenics. J. Am. Soc. Nephrol. 10, 2085–2086 (2009).
Tishon, A., Salmi, A., Ahmed, R. & Oldstone, M. B. Role of viral strains and host genes in determining levels of immune complexes in a model system: implications for HIV infection. AIDS Res. Hum. Retroviruses 7, 963–969 (1991).
Stephens, E. B., Tian, C., Dalton, S. B. & Gattone, V. H. 2nd Simian-human immune deficiency virus-associated nephropathy in macaques. AIDS Res. Hum. Retroviruses 16, 1295–1306 (2000).
Liu, Z.Q. et al. Derivation and biological characterization of a molecular clone of SHIV (KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques. Virology 260, 295–307 (1999).
Alpers, C. E. et al. Focal segmental glomerulosclerosis in primates infected with a simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 13, 413–424 (1997).
Strauss, J. et al. Renal disease in children with the acquired immunodeficiency syndrome. N. Engl. J. Med. 321, 625–630 (1989).
McCulloch, M. I. & Ray, P. E. Kidney disease in HIV-positive children. Sem. Nephrol. 28, 585–594 (2008).
D'Agati, V. & Appel, G. B. HIV infection and the kidney. J. Am. Soc. Nephrol. 8, 138–152 (1997).
Cohen, A. H. & Nast, C. C. HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion. Mod. Pathol. 1, 87–97 (1988).
Lee, C. J. et al. The clinicopathologic significance of endothelial tubuloreticular inclusions in glomerular diseases. Ultrastruct. Pathol. 37, 386–394 (2013).
Markowitz, G. S., Nasr, S. H., Stokes, M. B. & D'Agati, V. D. Treatment with IFN-α, -β, or -γ is associated with collapsing focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 5, 607–615 (2010).
Orenstein, J. M., Preble, O. T., Kind, P. & Schulof, R. The relationship of serum alpha-interferon and ultrastructural markers in HIV-seropositive individuals. Ultrastruct. Pathol. 11, 673–679 (1987).
Nebuloni, M. et al. Glomerular lesions in HIV-positive patients: a 20-year biopsy experience from Northern Italy. Clin. Nephrol. 72, 38–45 (2009).
Nasr, S. H., Radhakrishnan, J. & D'Agati, V. D. Bacterial infection-related glomerulonephritis in adults. Kidney Int. 83, 792–803 (2013).
Nissenson, A. R., Baraff, L. J., Fine, R. N. & Knutson, D. W. Poststreptococcal acute glomerulonephritis: fact and controversy. Ann. Intern. Med. 91, 76–86 (1979).
Balow, J. E. Nephropathy in the context of HIV infection. Kidney Int. 67, 1632–1633 (2005).
Johnson, R. J. & Couser, W. G. Hepatitis B infection and renal disease: clinical immunopathogenetic and therapeutic considerations. Kidney Int. 37, 663–676 (1990).
Meyers, C. M., Seef, L. B., Stehman-Breen, C. O. & Hoofnagle, J. H. Hepatitis C and renal disease: an update. Am. J. Kidney Dis. 42, 631–657 (2003).
Sethi, S. & Fervenza, F. C. Membranoproliferative glomerulonephritis — a new look at an old entity. N. Engl. J. Med. 366, 1119–1113 (2012).
Beck, L. H. et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Eng. J. Med. 361, 11–21 (2009).
Alarcon-Zurita, A. et al. Membranous glomerulonephritis with nephrotic syndrome in a HIV positive patient-remarkable remission with triple therapy. Nephrol. Dial. Transplant. 15, 1097–1098 (2000).
Lai, K. N. et al. Membranous nephropathy related to hepatitis B virus in adults. N. Engl. J. Med. 324, 1457–1463 (1991).
Stehman-Breen, C., Alpers, C. E., Couser, W. G., Willson, R. & Johnson, R. J. Hepatitis C virus associated membranous glomerulonephritis. Clin. Nephrol. 44, 141–147 (1995).
George, E. et al. The impact of hepatitis C coinfection on kidney disease related to human immunodeficiency virus (HIV): a biopsy study. Medicine (Baltimore) 90, 289–295 (2011).
Scotto, G. et al. Cryoglobulinemia in subjects with HCV infection alone, HIV infection, and HCV/HIV coinfection. J. Infect. 52, 294–299 (2006).
Dimitrakopoulos, A., Kordossis, T., Hatzakis, A. & Moutsopoulos, H. M. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann. Intern. Med. 130, 226–230 (1999).
Haas, M., Rajaraman, S., Ahuja, T., Kittaka, M. & Cavallo, T. Fibrillary/immunotactoid glomerulonephritis in HIV-positive patients: a report of three cases. Nephrol. Dial. Transplant. 15, 1679–1683 (2000).
Martin, J. L., Thomas, D. & Colindres, R. E. Immunotactoid glomerulopathy in an HIV-positive African-American man. Am. J. Kidney Dis. 42, E6–E10 (2003).
Alpers, C. E. & Kowalewska, J. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J. Am. Soc. Nephrol. 19, 34–37 (2008).
Rosenstock, J. L. et al. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int. 63, 1450–1461 (2003).
Laurinavicius, A., Hurwitz, S. & Rennke, H. G. Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathologic and follow-up study. Kidney Int. 56, 2203–2213 (1999).
Austin, H. A. 3rd, Boumpas, D. T., Vaughan, E. M. & Balow, J. E. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int. 45, 544–550 (1994).
Haas, M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am. J. Kidney Dis. 29, 829–842 (1997).
D'Amico, G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am. J. Kidney Dis. 36, 227–237 (2000).
The authors declare no competing financial interests.
About this article
Cite this article
Nobakht, E., Cohen, S., Rosenberg, A. et al. HIV-associated immune complex kidney disease. Nat Rev Nephrol 12, 291–300 (2016). https://doi.org/10.1038/nrneph.2015.216
This article is cited by
BMC Nephrology (2022)
BMC Nephrology (2020)
Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases
BMC Nephrology (2018)
Delineation of autoantibody repertoire through differential proteogenomics in hepatitis C virus-induced cryoglobulinemia
Scientific Reports (2016)